MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial (METEOR-CRATR)
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial (METEOR-CRATR)
Sponsor: National Cancer Institute (NCI)
A NA clinical study on Cancer of the Cervix and Cancer of the Pancreas, this trial is actively recruiting participants. The trial is conducted by National Cancer Institute (NCI) and has accumulated 11 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Dec 2025 — Present [monthly]
Recruiting NA
-
Sep 2025 — Dec 2025 [monthly]
Recruiting NA
-
Apr 2025 — Sep 2025 [monthly]
Recruiting NA
-
Jan 2025 — Apr 2025 [monthly]
Recruiting NA
-
Oct 2024 — Jan 2025 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
Phase: None → NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Jan 2024 — May 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2023 — Jan 2024 [monthly]
Not Yet Recruiting
-
Sep 2023 — Nov 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- The Foundation for Barnes-Jewish Hospital
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .